Back to Search
TRAVIS MOK, MD
MD
Emergency Medicine Physician
NPI: 1104455963IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
99363(GA)
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 2020
Research & Publications (20)
PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.
PMID 19346318·Am J Respir Cell Mol Biol·2010
8-other
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
PMID 18327706·Breast Cancer Res Treat·2009
4-observational
Bilateral brachial neuropathy and acute aortic dissection due to giant cell arteritis.
PMID 19288043·J Neurol·2009
5-case
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm.
PMID 19658185·Cancer·2009
6-review
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
PMID 19075267·J Clin Oncol·2009
8-other
Third generation triplet cytotoxic chemotherapy in advanced non-small cell lung cancer: a systematic overview.
PMID 18809226·Lung Cancer·2009
6-review
Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27.
PMID 19576211·Exp Cell Res·2009
8-other
CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
PMID 19509237·Cancer Res·2009
8-other
Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
PMID 19276259·Clin Cancer Res·2009
8-other
Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.
PMID 19381876·Pathol Oncol Res·2009
8-other
New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
PMID 19064965·J Clin Oncol·2009
3-trial
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy.
PMID 17762933·Cancer Chemother Pharmacol·2008
3-trial
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.
PMID 19027483·Lancet·2008
3-trial
Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
PMID 18715616·Hum Pathol·2008
8-other
Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.
PMID 18192473·J Vasc Interv Radiol·2008
3-trial
Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.
PMID 18216102·J Virol·2008
4-observational
Systemic nonhormonal management of advanced prostate cancer and its likely impact on patients' survival and quality of life.
PMID 18525325·Anticancer Drugs·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 185 SOUTH ORANGE AVE, MSB E-609
NEWARK, NJ 07103 - Phone
- (973) 972-9261
Quick Facts
- NPI
- 1104455963
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile